These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1375798)

  • 21. Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma.
    Pich A; Marmont F; Chiusa L; Cappello N; Resegotti L; Navone R
    Br J Haematol; 1992 Dec; 82(4):681-8. PubMed ID: 1482655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic criteria for classification and differential diagnosis of chronic myeloproliferative disorders.
    Frisch B; Bartl R; Burkhardt R; Jäger K
    Haematologia (Budap); 1984; 17(2):209-26. PubMed ID: 6534829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elliptic Fourier analysis of megakaryocyte nuclei in chronic myeloproliferative disorders.
    Nafe R; Kaloutsi V; Choritz H; Georgii A
    Anal Quant Cytol Histol; 1992 Oct; 14(5):391-7. PubMed ID: 1299229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Megakaryopoiesis in chronic myeloproliferative disorders: immunohistochemical evaluation of endoreduplicative activity by PCNA-staining reaction.
    Thiele J; Titius BR; Kvasnicka HM; Rechmeier W; Fischer R
    Anal Cell Pathol; 1994 Jul; 7(1):63-75. PubMed ID: 7981137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic myeloproliferative disorders (CMPD).
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    Pathol Res Pract; 1984 Nov; 179(2):131-86. PubMed ID: 6395125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic megakaryocytic-granulocytic myelosis--an electron microscopic study. I. Megakaryocytes and thrombocytes.
    Thiele J; Ballard AC; Georgii A; Vykoupil KF
    Virchows Arch A Pathol Anat Histol; 1977 Apr; 373(3):191-211. PubMed ID: 140504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A; Chiarle R; Chiusa L; Palestro G
    Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AgNORs and myeloma prognosis.
    Pich A; Chiusa L; Boccadoro M; Marmont F
    Leuk Lymphoma; 1994 Feb; 12(5-6):383-94. PubMed ID: 8180602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts.
    Buhr T; Georgii A; Schuppan O; Amor A; Kaloutsi V
    Ann Hematol; 1992 Jun; 64(6):286-91. PubMed ID: 1637884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histological diagnosis of Ph-negative myeloproliferative neoplasia. An overview].
    Campr V
    Cesk Patol; 2011 Jul; 47(3):84-93. PubMed ID: 21887923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleolar organizer regions in acute and chronic leukaemias.
    Iványi JL; Kiss A; Telek B
    Acta Histochem; 1992; 93(2):453-61. PubMed ID: 1288049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of bone marrow biopsy in chronic myeloid leukaemia.
    Seewann HL; Lehnert M; Jüttner F
    Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R; Bartl R; Jäger K; Frisch B; Kettner G; Mahl G; Sund M
    J Clin Pathol; 1986 Mar; 39(3):237-52. PubMed ID: 3457024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Megakaryopoiesis in chronic myeloproliferative disorders].
    Nagasawa T
    Rinsho Ketsueki; 1993 May; 34(5):551-6. PubMed ID: 8315826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.
    Cashell AW; Buss DH
    Ann Hematol; 1992 Jun; 64(6):273-6. PubMed ID: 1637881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LAT (linker for activation of T cells): a useful marker for megakaryocyte evaluation on bone marrow biopsies].
    Ungari M; Pellegrini W; Borlenghi E; Marocolo D; Ubiali A; Agazzi C; Pich A; Franco V; Facchetti F
    Pathologica; 2002 Dec; 94(6):325-30. PubMed ID: 12540999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Satellite nucleoli in the megakaryocytic lineage of rats.
    Janoutová J; Likovský Z; Smetana K
    Physiol Res; 2001; 50(1):113-7. PubMed ID: 11300222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.